Yamabe Noriko, Yokozawa Takako, Kim Hyun Young, Cho Eun Ju
Institute of Natural Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan.
J Pharm Pharmacol. 2005 Dec;57(12):1637-44. doi: 10.1211/jpp.57.12.0014.
The protective effect of Hachimi-jio-gan extract against chronic renal failure in a subtotal nephrectomy rat model was investigated. The level of serum urea nitrogen by nephrectomy was increased over 15 weeks, but the administration of Hachimi-jio-gan at 50 and 200 mg led to the decrease. In addition, the levels of creatinine (Cr), urinary methylguanidine (MG) and MG/Cr were increased, whereas Cr clearance dramatically decreased in nephrectomized rats. However, oral administration of Hachimi-jio-gan extract prevented the elevation of these uremic toxins in serum and urine, and the production of hydroxyl radical. Moreover, nephrectomy led to a significant decline in superoxide dismutase (SOD) and catalase activities, but increased glutathione peroxidase activity compared with normal levels, indicating an abnormal antioxidative system. The increased activity of both SOD and catalase by the oral administration of Hachimi-jio-gan suggested that these enzymes are associated with the protective role of Hachimi-jio-gan extract against oxidative stress by nephrectomy. Moreover, the decrease in serum albumin in nephrectomized control rats was increased and proteinuria was ameliorated by the administration of Hachimi-jio-gan with improved glomerular hyalinosis, interstitial fibrosis and inflammation, suggesting the beneficial effect of Hachimi-jio-gan to prevent glomerular sclerosis and progressive renal fibrosis. This study suggests that Hachimi-jio-gan plays a protective role in the progression of chronic renal failure through the decline in uremic toxins, elevation of antioxidative enzyme activity such as SOD and catalase, and amelioration of histopathological lesions in the kidney.
研究了八味地黄丸提取物对大鼠肾大部切除慢性肾衰竭模型的保护作用。肾切除术后15周内血清尿素氮水平升高,但给予50和200mg八味地黄丸可使其降低。此外,肾切除大鼠的肌酐(Cr)、尿甲基胍(MG)水平及MG/Cr升高,而肌酐清除率显著降低。然而,口服八味地黄丸提取物可防止血清和尿液中这些尿毒症毒素升高以及羟基自由基的产生。此外,肾切除术导致超氧化物歧化酶(SOD)和过氧化氢酶活性显著下降,但谷胱甘肽过氧化物酶活性与正常水平相比升高,表明抗氧化系统异常。口服八味地黄丸使SOD和过氧化氢酶活性均增加,提示这些酶与八味地黄丸提取物对肾切除所致氧化应激的保护作用有关。此外,肾切除对照大鼠血清白蛋白降低,给予八味地黄丸后蛋白尿改善,肾小球透明变性、间质纤维化和炎症减轻,提示八味地黄丸对预防肾小球硬化和进行性肾纤维化有益。本研究表明,八味地黄丸通过降低尿毒症毒素、提高SOD和过氧化氢酶等抗氧化酶活性以及改善肾脏组织病理学损伤,在慢性肾衰竭进展中发挥保护作用。